Effect of Candesartan on the development of diabetic retinopathy in a diabetes mouse model

被引：0
|
作者：
Qin, Peng [1 ]
Lo, Amy C. Y. [1 ]
Wong, Ian [1 ]
机构：
[1] Univ Hong Kong, Ophthalmol, Hong Kong, Hong Kong, Peoples R China
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
191
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Effect of Metformin on the Development of Diabetic Retinopathy
    Ryu, Christina
    Munie, Metasebia
    Noorulla, Salma
    Edwards, Paul
    Qiao, Xiaoxi
    Gao, Hua
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [12] Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes
    Yu, Jeremy Y.
    Du, Mei
    Elliott, Michael H.
    Wu, Mingyuan
    Fu, Dongxu
    Yang, Shihe
    Basu, Arpita
    Gu, Xiaowu
    Ma, Jian-Xing
    Aston, Christopher E.
    Lyons, Timothy J.
    DIABETOLOGIA, 2016, 59 (09) : 2026 - 2035
  • [13] Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes
    Jeremy Y. Yu
    Mei Du
    Michael H. Elliott
    Mingyuan Wu
    Dongxu Fu
    Shihe Yang
    Arpita Basu
    Xiaowu Gu
    Jian-Xing Ma
    Christopher E. Aston
    Timothy J. Lyons
    Diabetologia, 2016, 59 : 2026 - 2035
  • [14] THE DEVELOPMENT OF DIABETIC RETINOPATHY - EFFECTS OF DURATION AND CONTROL OF DIABETES
    HARDIN, RC
    JACKSON, RL
    JOHNSTON, TL
    KELLY, HG
    DIABETES, 1956, 5 (05) : 397 - 405
  • [15] Increased Synthesis of Leukotrienes in the Mouse Model of Diabetic Retinopathy
    Talahalli, Ramaprasad
    Zarini, Simona
    Sheibani, Nader
    Murphy, Robert C.
    Gubitosi-Klug, Rose A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (03) : 1699 - 1708
  • [16] Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials
    M. Porta
    J. W. Hainer
    S.-O. Jansson
    A. Malm
    R. Bilous
    N. Chaturvedi
    J. H. Fuller
    R. Klein
    T. Orchard
    H.-H. Parving
    A.-K. Sjølie
    Diabetologia, 2011, 54 : 1298 - 1303
  • [17] Baseline data from the diabetic retinopathy candesartan trials (DIRECT)
    Charbonnel, B.
    Massin, P.
    HYPERTENSION, 2006, 48 (04) : 780 - 780
  • [18] Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials
    Porta, M.
    Hainer, J. W.
    Jansson, S. -O.
    Malm, A.
    Bilous, R.
    Chaturvedi, N.
    Fuller, J. H.
    Klein, R.
    Orchard, T.
    Parving, H. -H.
    Sjolie, A. -K.
    DIABETOLOGIA, 2011, 54 (06) : 1298 - 1303
  • [19] Candesartan May Reduce the Incidence and Reverse the Progression of Diabetic Retinopathy
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2008, 10 (11): : 1131 - 1131
  • [20] The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
    Warnold, I
    Price, G
    Aldington, S
    Deveney, A
    Holloway, J
    Janiak, R
    Kenny, D
    Krisin, E
    Lipinski, H
    Otterbeck, N
    Strannelind, P
    Tillin, T
    Wilhelmsen, L
    Bird, A
    Wedel, H
    Agardh, CD
    Bilous, R
    Bonnici, F
    Charbonnel, B
    Cooper, M
    Dedov, I
    Gardiner, R
    Gomis, R
    Ilkova, H
    Katsilambros, N
    Kerenyi, Z
    Martin, S
    Massin, P
    Pirags, V
    Porta, M
    Raz, I
    Schernthaner, G
    Shestakova, M
    Sjolie, AK
    Strojek, K
    Puu, M
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2005, 6 (01) : 25 - 32
12345